These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 126365)

  • 1. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. IV. Dissociation rate constants for complexes of the enzyme with cardiac oligodigitoxides.
    Yoda S; Sarrif AM; Yoda A
    Mol Pharmacol; 1975 Sep; 11(5):647-52. PubMed ID: 126365
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. 3. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of sodium, magnesium, and adenosine triphosphate.
    Yoda A; Yoda S
    Mol Pharmacol; 1974 May; 10(3):494-500. PubMed ID: 4277671
    [No Abstract]   [Full Text] [Related]  

  • 3. Structue-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. I. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of magnesium and phosphate.
    Yoda A
    Mol Pharmacol; 1973 Jan; 9(1):51-60. PubMed ID: 4265446
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. II. Association rate constants of various enzyme-cardiac glycoside complexes.
    Yoda A; Yoda S; Sarrif AM
    Mol Pharmacol; 1973 Nov; 9(6):766-73. PubMed ID: 4271632
    [No Abstract]   [Full Text] [Related]  

  • 5. Association and dissociation rate constants of the complexes between various cardiac aglycones and sodium- and potassium-dependent adenosine triphosphatase formed in the presence of magnesium and phosphate.
    Yoda A; Yoda S
    Mol Pharmacol; 1977 Mar; 13(2):352-61. PubMed ID: 140301
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of calf brain membranal sodium- and potassium-dependent adenosine triphosphatase by cardioactive sterols. A binding site model.
    Wilson WE; Sivitz WI; Hanna LT
    Mol Pharmacol; 1970 Sep; 6(5):449-59. PubMed ID: 4248266
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of inhibition of sodium- and potassium-dependent adenosine triphosphatase by tricyclic antipsychotics.
    Palatini P
    Mol Pharmacol; 1977 Mar; 13(2):216-23. PubMed ID: 192990
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of sodium- and potassium-dependent adenosine triphosphatase by N-ethylmaleimide. I. Effects on sodium-sensitive phosphorylation and potassium-sensitive dephosphorylation.
    Banerjee SP; Wong SM; Khanna VK; Sen AK
    Mol Pharmacol; 1972 Jan; 8(1):8-17. PubMed ID: 4258649
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for two forms of fluoride-treated sodium- and potassium-dependent adenosine triphosphatase.
    Penzotti SC; Titus E
    Mol Pharmacol; 1972 Mar; 8(2):149-58. PubMed ID: 4260221
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of pH on the interaction of cardiotonic steroids with sodium- and potasssium-dependent adenosine triphosphatase.
    Yoda A; Yoda S
    Mol Pharmacol; 1978 Jul; 14(4):624-32. PubMed ID: 28472
    [No Abstract]   [Full Text] [Related]  

  • 11. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. V. Dissociation rate constants of digitoxin acetates.
    Yoda A; Yoda S
    Mol Pharmacol; 1975 Sep; 11(5):653-62. PubMed ID: 126366
    [No Abstract]   [Full Text] [Related]  

  • 12. Association and dissociation rate constants of the complexes between various cardiac monoglycosides and Na, K-ATPase.
    Yoda A
    Ann N Y Acad Sci; 1974; 242(0):598-616. PubMed ID: 4279608
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibiotics as tools for metabolic studies. XVIII. Inhibition of sodium- and potassium-dependent adenosine triphosphatase.
    Susa JB; Lardy HA
    Mol Pharmacol; 1975 Mar; 11(2):166-73. PubMed ID: 123632
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of sodium- and potassium-dependent adenosine triphosphatase by N-ethylmaleimide. II. Effects of sodium-activated transphosphorylation.
    Banerjee SP; Wong SM; Sen AK
    Mol Pharmacol; 1972 Jan; 8(1):18-29. PubMed ID: 4258646
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemistry, biochemistry and clinical pharmacology of digitalis glycosides. An overview].
    Dwenger A
    Arzneimittelforschung; 1973 Oct; 23(10):1439-46. PubMed ID: 4273089
    [No Abstract]   [Full Text] [Related]  

  • 16. [Activity and properties of adenosine triphosphatase in erythrocytes and various tissues (brain, liver, kidney, small intestine mucosa) of cattle].
    Kolb E; Schineff C
    Arch Exp Veterinarmed; 1975 Dec; 29(6):839-55. PubMed ID: 132147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of digitonin on some enzyme activities of the sodium pump.
    Winter CG
    Biochim Biophys Acta; 1972 Apr; 266(1):135-43. PubMed ID: 4339318
    [No Abstract]   [Full Text] [Related]  

  • 18. Kinetics of oligomycin inhibition of sodium- and potassium-activated adenosine triphosphatase from beef brain.
    Inturrisi CE; Titus E
    Mol Pharmacol; 1968 Nov; 4(6):591-9. PubMed ID: 4235717
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversibility of the interaction of strophanthidin bromoacetate with the cardiotonic steroid binding site of sodium- and potassium-dependent adenosine triphosphatase.
    Tobin T; Akera T; Ku D; Lu MC
    Mol Pharmacol; 1973 Sep; 9(5):676-85. PubMed ID: 4274674
    [No Abstract]   [Full Text] [Related]  

  • 20. The interaction between chlorpromazine free radical and microsomal sodium- and potassium-activated adenosine triphosphatase from rat brain.
    Akera T; Brody TM
    Mol Pharmacol; 1969 Nov; 5(6):605-14. PubMed ID: 4244695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.